Treace Medical Concepts (TMCI) Competitors

$2.78 0.00 (0.00%)

Closing price 05/22/2026 04:00 PM Eastern

Extended Trading

$2.91 +0.13 (+4.68%)

As of 05/22/2026 06:29 PM Eastern

TMCI vs. SGP, SIBN, CBLL, BWAY, and NPCE

Should you buy Treace Medical Concepts stock or one of its competitors? MarketBeat compares Treace Medical Concepts with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Treace Medical Concepts include Spyglass Pharma (SGP), SiBone (SIBN), CeriBell (CBLL), Brainsway (BWAY), and NeuroPace (NPCE). These companies are all part of the "medical equipment" industry.

How does Treace Medical Concepts compare to Spyglass Pharma?

Treace Medical Concepts (NASDAQ:TMCI) and Spyglass Pharma (NASDAQ:SGP) are both small-cap medical equipment companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, dividends, institutional ownership, profitability, risk, earnings, analyst recommendations and valuation.

Spyglass Pharma has a net margin of 0.00% compared to Treace Medical Concepts' net margin of -29.44%. Spyglass Pharma's return on equity of 0.00% beat Treace Medical Concepts' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Treace Medical Concepts	-29.44%	-67.04%	-30.28%
Spyglass Pharma	N/A	N/A	N/A

In the previous week, Spyglass Pharma had 1 more articles in the media than Treace Medical Concepts. MarketBeat recorded 2 mentions for Spyglass Pharma and 1 mentions for Treace Medical Concepts. Treace Medical Concepts' average media sentiment score of 0.58 beat Spyglass Pharma's score of 0.00 indicating that Treace Medical Concepts is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Treace Medical Concepts	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Spyglass Pharma	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Treace Medical Concepts currently has a consensus target price of $4.77, indicating a potential upside of 71.58%. Spyglass Pharma has a consensus target price of $45.00, indicating a potential upside of 115.93%. Given Spyglass Pharma's stronger consensus rating and higher probable upside, analysts plainly believe Spyglass Pharma is more favorable than Treace Medical Concepts.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Treace Medical Concepts	2 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.86
Spyglass Pharma	0 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.83

Spyglass Pharma has lower revenue, but higher earnings than Treace Medical Concepts.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Treace Medical Concepts	$212.69M	0.85	-$59M	-$0.97	N/A
Spyglass Pharma	N/A	N/A	N/A	N/A	N/A

84.1% of Treace Medical Concepts shares are owned by institutional investors. 23.4% of Treace Medical Concepts shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

Spyglass Pharma beats Treace Medical Concepts on 7 of the 11 factors compared between the two stocks.

How does Treace Medical Concepts compare to SiBone?

SiBone (NASDAQ:SIBN) and Treace Medical Concepts (NASDAQ:TMCI) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, dividends, analyst recommendations, institutional ownership, media sentiment, valuation, earnings and profitability.

SiBone has a beta of 0.67, indicating that its stock price is 33% less volatile than the broader market. Comparatively, Treace Medical Concepts has a beta of 1.1, indicating that its stock price is 10% more volatile than the broader market.

In the previous week, SiBone had 2 more articles in the media than Treace Medical Concepts. MarketBeat recorded 3 mentions for SiBone and 1 mentions for Treace Medical Concepts. Treace Medical Concepts' average media sentiment score of 0.58 beat SiBone's score of -0.70 indicating that Treace Medical Concepts is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
SiBone	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Negative
Treace Medical Concepts	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

SiBone has a net margin of -8.10% compared to Treace Medical Concepts' net margin of -29.44%. SiBone's return on equity of -9.56% beat Treace Medical Concepts' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SiBone	-8.10%	-9.56%	-7.06%
Treace Medical Concepts	-29.44%	-67.04%	-30.28%

98.1% of SiBone shares are held by institutional investors. Comparatively, 84.1% of Treace Medical Concepts shares are held by institutional investors. 4.0% of SiBone shares are held by company insiders. Comparatively, 23.4% of Treace Medical Concepts shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

SiBone has higher earnings, but lower revenue than Treace Medical Concepts. SiBone is trading at a lower price-to-earnings ratio than Treace Medical Concepts, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SiBone	$200.93M	3.24	-$18.90M	-$0.39	N/A
Treace Medical Concepts	$212.69M	0.85	-$59M	-$0.97	N/A

SiBone currently has a consensus price target of $23.00, indicating a potential upside of 56.68%. Treace Medical Concepts has a consensus price target of $4.77, indicating a potential upside of 71.58%. Given Treace Medical Concepts' higher possible upside, analysts plainly believe Treace Medical Concepts is more favorable than SiBone.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SiBone	1 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.71
Treace Medical Concepts	2 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.86

Summary

SiBone beats Treace Medical Concepts on 10 of the 16 factors compared between the two stocks.

How does Treace Medical Concepts compare to CeriBell?

CeriBell (NASDAQ:CBLL) and Treace Medical Concepts (NASDAQ:TMCI) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, risk, valuation, earnings, institutional ownership, analyst recommendations, profitability and media sentiment.

CeriBell has a beta of 0.99, meaning that its stock price is 1% less volatile than the broader market. Comparatively, Treace Medical Concepts has a beta of 1.1, meaning that its stock price is 10% more volatile than the broader market.

CeriBell has higher earnings, but lower revenue than Treace Medical Concepts. CeriBell is trading at a lower price-to-earnings ratio than Treace Medical Concepts, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CeriBell	$89.06M	8.00	-$53.41M	-$1.63	N/A
Treace Medical Concepts	$212.69M	0.85	-$59M	-$0.97	N/A

84.1% of Treace Medical Concepts shares are held by institutional investors. 20.1% of CeriBell shares are held by company insiders. Comparatively, 23.4% of Treace Medical Concepts shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

In the previous week, CeriBell had 2 more articles in the media than Treace Medical Concepts. MarketBeat recorded 3 mentions for CeriBell and 1 mentions for Treace Medical Concepts. Treace Medical Concepts' average media sentiment score of 0.58 beat CeriBell's score of 0.20 indicating that Treace Medical Concepts is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CeriBell	0 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Treace Medical Concepts	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Treace Medical Concepts has a net margin of -29.44% compared to CeriBell's net margin of -63.51%. CeriBell's return on equity of -38.19% beat Treace Medical Concepts' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CeriBell	-63.51%	-38.19%	-30.92%
Treace Medical Concepts	-29.44%	-67.04%	-30.28%

CeriBell currently has a consensus target price of $22.20, suggesting a potential upside of 18.27%. Treace Medical Concepts has a consensus target price of $4.77, suggesting a potential upside of 71.58%. Given Treace Medical Concepts' higher possible upside, analysts clearly believe Treace Medical Concepts is more favorable than CeriBell.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CeriBell	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.83
Treace Medical Concepts	2 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.86

Summary

Treace Medical Concepts beats CeriBell on 10 of the 17 factors compared between the two stocks.

How does Treace Medical Concepts compare to Brainsway?

Treace Medical Concepts (NASDAQ:TMCI) and Brainsway (NASDAQ:BWAY) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, earnings, media sentiment, valuation, institutional ownership, dividends, analyst recommendations and profitability.

Treace Medical Concepts presently has a consensus target price of $4.77, indicating a potential upside of 71.58%. Brainsway has a consensus target price of $15.00, indicating a potential downside of 0.66%. Given Treace Medical Concepts' higher probable upside, equities analysts clearly believe Treace Medical Concepts is more favorable than Brainsway.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Treace Medical Concepts	2 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.86
Brainsway	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.75

Treace Medical Concepts has a beta of 1.1, meaning that its share price is 10% more volatile than the broader market. Comparatively, Brainsway has a beta of 1.23, meaning that its share price is 23% more volatile than the broader market.

Brainsway has lower revenue, but higher earnings than Treace Medical Concepts. Treace Medical Concepts is trading at a lower price-to-earnings ratio than Brainsway, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Treace Medical Concepts	$212.69M	0.85	-$59M	-$0.97	N/A
Brainsway	$52.22M	11.58	$7.57M	$0.35	43.14

84.1% of Treace Medical Concepts shares are held by institutional investors. Comparatively, 30.1% of Brainsway shares are held by institutional investors. 23.4% of Treace Medical Concepts shares are held by insiders. Comparatively, 19.0% of Brainsway shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

In the previous week, Treace Medical Concepts and Treace Medical Concepts both had 1 articles in the media. Treace Medical Concepts' average media sentiment score of 0.58 beat Brainsway's score of 0.00 indicating that Treace Medical Concepts is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Treace Medical Concepts	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Brainsway	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Brainsway has a net margin of 15.68% compared to Treace Medical Concepts' net margin of -29.44%. Brainsway's return on equity of 12.28% beat Treace Medical Concepts' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Treace Medical Concepts	-29.44%	-67.04%	-30.28%
Brainsway	15.68%	12.28%	7.75%

Summary

Brainsway beats Treace Medical Concepts on 10 of the 15 factors compared between the two stocks.

How does Treace Medical Concepts compare to NeuroPace?

Treace Medical Concepts (NASDAQ:TMCI) and NeuroPace (NASDAQ:NPCE) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, media sentiment, profitability, institutional ownership, dividends, earnings, analyst recommendations and valuation.

NeuroPace has lower revenue, but higher earnings than Treace Medical Concepts. NeuroPace is trading at a lower price-to-earnings ratio than Treace Medical Concepts, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Treace Medical Concepts	$212.69M	0.85	-$59M	-$0.97	N/A
NeuroPace	$99.99M	5.77	-$21.47M	-$0.65	N/A

Treace Medical Concepts has a beta of 1.1, meaning that its share price is 10% more volatile than the broader market. Comparatively, NeuroPace has a beta of 1.92, meaning that its share price is 92% more volatile than the broader market.

In the previous week, NeuroPace had 5 more articles in the media than Treace Medical Concepts. MarketBeat recorded 6 mentions for NeuroPace and 1 mentions for Treace Medical Concepts. Treace Medical Concepts' average media sentiment score of 0.58 beat NeuroPace's score of 0.51 indicating that Treace Medical Concepts is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Treace Medical Concepts	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
NeuroPace	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

NeuroPace has a net margin of -21.67% compared to Treace Medical Concepts' net margin of -29.44%. Treace Medical Concepts' return on equity of -67.04% beat NeuroPace's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Treace Medical Concepts	-29.44%	-67.04%	-30.28%
NeuroPace	-21.67%	-108.20%	-18.50%

Treace Medical Concepts currently has a consensus target price of $4.77, indicating a potential upside of 71.58%. NeuroPace has a consensus target price of $18.83, indicating a potential upside of 11.31%. Given Treace Medical Concepts' higher possible upside, equities research analysts clearly believe Treace Medical Concepts is more favorable than NeuroPace.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Treace Medical Concepts	2 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.86
NeuroPace	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	2 Strong Buy rating(s)	2.88

84.1% of Treace Medical Concepts shares are owned by institutional investors. Comparatively, 78.8% of NeuroPace shares are owned by institutional investors. 23.4% of Treace Medical Concepts shares are owned by insiders. Comparatively, 20.5% of NeuroPace shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

NeuroPace beats Treace Medical Concepts on 10 of the 17 factors compared between the two stocks.

Get Treace Medical Concepts News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TMCI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

TMCI vs. The Competition

Export

Metric	Treace Medical Concepts	MED INSTRUMENTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$180.34M	$6.97B	$6.43B	$12.32B
Dividend Yield	N/A	1.68%	2.76%	5.28%
P/E Ratio	-2.87	47.45	21.01	25.66
Price / Sales	0.85	84.61	615.84	111.99
Price / Cash	N/A	24.91	43.49	56.67
Price / Book	2.34	6.53	10.37	7.14
Net Income	-$59M	$158.81M	$3.57B	$335.98M
7 Day Performance	1.09%	3.72%	6.01%	3.56%
1 Month Performance	40.40%	0.74%	3.52%	2.54%
1 Year Performance	-52.72%	3.17%	34.13%	35.05%

Treace Medical Concepts Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
TMCI Treace Medical Concepts	3.1166 of 5 stars	$2.78 flat	$4.77 +71.6%	-52.7%	$180.34M	$212.69M	N/A	250	Gap Up
SGP Spyglass Pharma	N/A	$21.20 -4.7%	$45.00 +112.3%	N/A	$708.65M	N/A	N/A	65	Gap Up
SIBN SiBone	2.3446 of 5 stars	$14.84 +0.5%	$23.00 +55.0%	-20.1%	$654.59M	$200.93M	N/A	350
CBLL CeriBell	1.9492 of 5 stars	$16.96 +2.3%	$22.20 +30.9%	+13.2%	$629.09M	$89.06M	N/A	N/A	Positive News
BWAY Brainsway	1.8326 of 5 stars	$14.89 +0.1%	$15.00 +0.7%	+181.5%	$595.76M	$52.22M	42.51	120

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:TMCI) was last updated on 5/25/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Treace Medical Concepts (TMCI) Competitors

TMCI vs. SGP, SIBN, CBLL, BWAY, and NPCE

How does Treace Medical Concepts compare to Spyglass Pharma?

Summary

How does Treace Medical Concepts compare to SiBone?

Summary

How does Treace Medical Concepts compare to CeriBell?

Summary

How does Treace Medical Concepts compare to Brainsway?

Summary

How does Treace Medical Concepts compare to NeuroPace?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TMCI vs. The Competition

Treace Medical Concepts Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Treace Medical Concepts (TMCI) Competitors

TMCI vs. SGP, SIBN, CBLL, BWAY, and NPCE

How does Treace Medical Concepts compare to Spyglass Pharma?

Is TMCI or SGP more profitable?

Does the media favor TMCI or SGP?

Do analysts prefer TMCI or SGP?

Which has stronger earnings and valuation, TMCI or SGP?

Do institutionals and insiders believe in TMCI or SGP?

Summary

How does Treace Medical Concepts compare to SiBone?

Which has more volatility and risk, SIBN or TMCI?

Does the media refer more to SIBN or TMCI?

Is SIBN or TMCI more profitable?

Do insiders and institutionals have more ownership in SIBN or TMCI?

Which has preferable earnings & valuation, SIBN or TMCI?

Do analysts prefer SIBN or TMCI?

Summary

How does Treace Medical Concepts compare to CeriBell?

Which has more volatility and risk, CBLL or TMCI?

Which has better earnings and valuation, CBLL or TMCI?

Do insiders & institutionals hold more shares of CBLL or TMCI?

Does the media prefer CBLL or TMCI?

Is CBLL or TMCI more profitable?

Do analysts recommend CBLL or TMCI?

Summary

How does Treace Medical Concepts compare to Brainsway?

Do analysts recommend TMCI or BWAY?

Which has more risk & volatility, TMCI or BWAY?

Which has preferable valuation and earnings, TMCI or BWAY?

Do insiders and institutionals believe in TMCI or BWAY?

Does the media prefer TMCI or BWAY?

Is TMCI or BWAY more profitable?

Summary

How does Treace Medical Concepts compare to NeuroPace?

Which has better valuation and earnings, TMCI or NPCE?

Which has more risk & volatility, TMCI or NPCE?

Does the media favor TMCI or NPCE?

Is TMCI or NPCE more profitable?

Do analysts rate TMCI or NPCE?

Do institutionals & insiders believe in TMCI or NPCE?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TMCI vs. The Competition

Treace Medical Concepts Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools